Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Abstract

Cancer cell resistance to chemotherapy is still a heavy burden that impairs the response of many cancer patients to conventional chemotherapy. Using drug combinations is one therapeutic approach to overcome the developing resistance to any one drug. Oxidative stress is now a generally regarded hallmark of cancer that can be one approach to selectively target cancer cells while sparing normal cells. With the aim of increasing oxidative stress in cancer cells to a lethal set point, we have generated and combined several series of redox active compounds that act at different points of the cellular oxidative cascade. The premise of such combinations is to deplete of endogenous antioxidant defence proteins (e.g., Glutathione) while concomitantly increasing the generation of ROS via metal redox recycling and Fenton chemistry which eventually leads to the disruption of cellular redox homeostasis and induction of cell death. Through this approach, we have identified highly synergistic combinations of two distinctive classes of compounds (Azines and Copper(II) complexes of 2-pyridyl ketone thiosemicarbazones) which are capable of eliminating cancer cells without concomitant increase in toxicity toward normal cells. In one of our most potent combinations, a combination index (CI) value of 0.056 was observed, representing a 17 fold enhancement in activity beyond additive effects. Such new combination regimen of redox active compounds can be one step closer to potentially safer low dose chemotherapy.

Original languageEnglish
Pages (from-to)3097-3104
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume23
Issue number13
DOIs
Publication statusPublished - 08 Jun 2015

Fingerprint

Dive into the research topics of 'Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis'. Together they form a unique fingerprint.

Cite this